YADD mutants of human immunodeficiency virus type 1 and Moloney murine leukemia virus reverse transcriptase are resistant to lamivudine triphosphate (3TCTP) in vitro.
about
Reverse transcriptase in motion: conformational dynamics of enzyme-substrate interactions.Effect of lamivudine on transmission of human T-cell lymphotropic virus type 1 to adult peripheral blood mononuclear cells in vitroSusceptibility of the human retrovirus XMRV to antiretroviral inhibitors.Characterization of the polymerase and RNase H activities of human foamy virus reverse transcriptase.Activity of a novel combined antiretroviral therapy of gemcitabine and decitabine in a mouse model for HIV-1.The M184V mutation reduces the selective excision of zidovudine 5'-monophosphate (AZTMP) by the reverse transcriptase of human immunodeficiency virus type 1Mutation of the catalytic domain of the foamy virus reverse transcriptase leads to loss of processivity and infectivity.Nucleoside analog resistance caused by insertions in the fingers of human immunodeficiency virus type 1 reverse transcriptase involves ATP-mediated excision.Molecular impact of the M184V mutation in human immunodeficiency virus type 1 reverse transcriptase.5-methylcytosine-sensitive variants of Thermococcus kodakaraensis DNA polymerase.Retrovirus reverse transcriptases containing a modified YXDD motif.Discovery of drugs that possess activity against feline leukemia virusApparent defects in processive DNA synthesis, strand transfer, and primer elongation of Met-184 mutants of HIV-1 reverse transcriptase derive solely from a dNTP utilization defect.Xenotropic murine leukemia virus-related virus is susceptible to AZT.Structures of HIV-1 RT-DNA complexes before and after incorporation of the anti-AIDS drug tenofovir.
P2860
Q34092798-F73ED93C-2CEA-4A1C-B11E-79E2E4B4286EQ34113074-F02EBC36-F3B3-4B01-9C37-3BB9F83F3E52Q34128479-C8F65B0C-76C7-40D6-9D9A-6CAE90083E2CQ34186095-271B9D87-D78B-48CB-8AAD-75519559E593Q34249277-E1F6DD53-0FB9-48AE-9D82-FA78F3645D1DQ34334682-432E4A4D-6B8E-40BB-B4B1-3F66D516FDE3Q34343588-93DDE849-0F41-4A4F-A1A3-08D66D0DD7ACQ34345605-8987B996-56C2-48AB-9B34-750F8B2AEAB3Q35566910-10576D3B-9D4D-4BE8-BC2F-F5E3EB54B359Q36139113-71BF6EE5-BC23-4090-A901-A2E1B8985B9CQ36186797-EF4FA5B7-EB43-4B2F-999B-B17631B3C56EQ36525355-1A69AD84-392B-4F07-8CC9-0FA5F143B460Q36727282-06F546C6-81C1-4E54-8EB6-E93C06D83047Q41879645-556FE206-541E-40AC-8395-A8745E695992Q44859710-2DB229C6-6A84-4710-B75E-CEF5289EC984
P2860
YADD mutants of human immunodeficiency virus type 1 and Moloney murine leukemia virus reverse transcriptase are resistant to lamivudine triphosphate (3TCTP) in vitro.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
YADD mutants of human immunode ...... triphosphate (3TCTP) in vitro.
@en
type
label
YADD mutants of human immunode ...... triphosphate (3TCTP) in vitro.
@en
prefLabel
YADD mutants of human immunode ...... triphosphate (3TCTP) in vitro.
@en
P2093
P2860
P1433
P1476
YADD mutants of human immunode ...... triphosphate (3TCTP) in vitro
@en
P2093
P2860
P304
P356
10.1128/JVI.75.14.6321-6328.2001
P577
2001-07-01T00:00:00Z